Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M del Zompo

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Psychopharmacology|October 31, 1978
Parkinsonism by haloperidol and piribedilG U Corsini, M Del Zompo, A Spissu, et al.
Biochemical Pharmacology|December 15, 1984
Inhibition of [3H] MPTP binding to rat brain by pargylineM Del Zompo, A Bocchetta, M P Piccardi, et al.
Journal of Chemotherapy (Florence, Italy)|April 17, 2008
Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newbornsM Testa, V Fanos, V Martinelli, et al.
Pharmacological Research Communications|December 1, 1988
Correlation with 3H-MPP+ binding sites by debrisoquin and some analogues in mouse brainS Ruju, M Del Zompo, M P Piccardi, et al.
European Journal of Pharmacology|September 17, 1991
High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular locationM Del Zompo, M P Piccardi, S Ruiu, et al.
Neuropharmacology|December 1, 1981
The use of dopamine agonists in the treatment of schizophreniaG U Corsini, G F Pitzalis, F Bernardi, et al.
Advances in Neurology|January 1, 1987
Characterization of [3H]MPTP binding sitesG U Corsini, S Pintus, A Bocchetta, et al.
Biochemical Pharmacology|November 1, 1988
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.
Journal of Neurochemistry|June 1, 1990
[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterizationM Del Zompo, S Ruiu, R Maggio, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseG U Corsini, S Pintus, A Bocchetta, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Psychopharmacology|October 31, 1978
Parkinsonism by haloperidol and piribedilG U Corsini, M Del Zompo, A Spissu, et al.
Biochemical Pharmacology|December 15, 1984
Inhibition of [3H] MPTP binding to rat brain by pargylineM Del Zompo, A Bocchetta, M P Piccardi, et al.
Journal of Chemotherapy (Florence, Italy)|April 17, 2008
Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newbornsM Testa, V Fanos, V Martinelli, et al.
Pharmacological Research Communications|December 1, 1988
Correlation with 3H-MPP+ binding sites by debrisoquin and some analogues in mouse brainS Ruju, M Del Zompo, M P Piccardi, et al.
European Journal of Pharmacology|September 17, 1991
High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular locationM Del Zompo, M P Piccardi, S Ruiu, et al.
Neuropharmacology|December 1, 1981
The use of dopamine agonists in the treatment of schizophreniaG U Corsini, G F Pitzalis, F Bernardi, et al.
Advances in Neurology|January 1, 1987
Characterization of [3H]MPTP binding sitesG U Corsini, S Pintus, A Bocchetta, et al.
Biochemical Pharmacology|November 1, 1988
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.
Journal of Neurochemistry|June 1, 1990
[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterizationM Del Zompo, S Ruiu, R Maggio, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseG U Corsini, S Pintus, A Bocchetta, et al.
Pageof 8